Sjögren症候群患者の唾液腺腺房構造破壊阻止:―セファランチンの有効性に関する臨床病理学的研究― Prevention of the destruction of acinar structure in patients with Sjögren's syndrome:—Clinicopathological study on the effectiveness of cepharanthin—

Access this Article

Author(s)

    • 青田 桂子 AOTA Keiko
    • 徳島大学大学院ヘルスバイオサイエンス研究部口腔内科学分野 Department of Oral Medicine, Institute of Health Biosciences, The University of Tokushima Graduate Faculty of Dentistry
    • 山村 佳子 YAMAMURA Yoshiko
    • 徳島大学大学院ヘルスバイオサイエンス研究部口腔内科学分野 Department of Oral Medicine, Institute of Health Biosciences, The University of Tokushima Graduate Faculty of Dentistry
    • 可児 耕一 [他] KANI Koichi
    • 徳島大学大学院ヘルスバイオサイエンス研究部口腔内科学分野 Department of Oral Medicine, Institute of Health Biosciences, The University of Tokushima Graduate Faculty of Dentistry
    • 高野 栄之 TAKANO Hideyuki
    • 徳島大学大学院ヘルスバイオサイエンス研究部口腔内科学分野 Department of Oral Medicine, Institute of Health Biosciences, The University of Tokushima Graduate Faculty of Dentistry
    • 茂木 勝美 MOTEGI Katsumi
    • 徳島大学大学院ヘルスバイオサイエンス研究部口腔内科学分野 Department of Oral Medicine, Institute of Health Biosciences, The University of Tokushima Graduate Faculty of Dentistry
    • 桃田 幸弘 MOMOTA Yukihiro
    • 徳島大学大学院ヘルスバイオサイエンス研究部口腔内科学分野 Department of Oral Medicine, Institute of Health Biosciences, The University of Tokushima Graduate Faculty of Dentistry
    • 石丸 直澄 ISHIMARU Naozumi
    • 徳島大学大学院ヘルスバイオサイエンス研究部口腔内科学分野|徳島大学大学院ヘルスバイオサイエンス研究部口腔分子病態学分野 Department of Oral Medicine, Institute of Health Biosciences, The University of Tokushima Graduate Faculty of Dentistry|Department of Oral Molecular Pathology, Institute of Health Biosciences, The University of Tokushima Graduate Faculty of Dentistry
    • 東 雅之 AZUMA Masayuki
    • 徳島大学大学院ヘルスバイオサイエンス研究部口腔内科学分野 Department of Oral Medicine, Institute of Health Biosciences, The University of Tokushima Graduate Faculty of Dentistry

Abstract

Sjögren's syndrome (SS) is characterized by the eventual total replacement of the acinar structure by marked infiltration of lymphocytes into the salivary and lacrimal glands. We previously demonstrated that tumor necrosis factor-α (TNF-α) induced matrix metalloproteinase-9 (MMP-9) production by the stimulating transcription factor, nuclear factor-κB (NF-κB), in human salivary gland acinar cells and that cepharanthin, a biscoclaurine alkaloid, prevented the activation of TNF-α-induced NF-κB activity. In addition, we have shown that cepharanthin prevented the destruction of acinar tissues in murine SS. Thus, in this study, we investigated the clinicopathological effect of cepharanthin on the patients with SS. <br>Ten patients with a diagnosis of primary SS were enrolled in this study. They were treated with cepharanthin for three months, followed by the evaluation of salivary production, C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), anti-SS-A antibody, anti-SS-B antibody, pathological examination of labial salivary gland biopsy specimens, and the symptom of drymouth. <br>Average salivary production was 4.25ml/10minutes before the study. This average production increased to 6.46ml/10minutes after the study. There were no remarkable changes in CRP, ESR, anti-SS-A antibody and anti-SS-B antibody. In pathological findings, although the decreases in infiltration of lymphocytes were observed in 5 out of 5 cases, the reduction of destruction of acinar structures was clearly detected in 5 cases. Improvement of symptom of drymouth was detected in 7 out of 10 cases. <br>These observations suggest that cepharanthin treatment might provide an efficient and useful therapeutic approach for countering the destruction of acinar tissue in salivary glands of patients with SS.

Journal

  • Journal of The Japanese Stomatological Society

    Journal of The Japanese Stomatological Society 62(4), 254-261, 2013

    Japanese Stomatological Society

Codes

  • NII Article ID (NAID)
    130004781800
  • NII NACSIS-CAT ID (NCID)
    AN00189050
  • Text Lang
    ENG
  • ISSN
    0029-0297
  • NDL Article ID
    024942967
  • NDL Call No.
    Z19-215
  • Data Source
    NDL  J-STAGE 
Page Top